Muscarinic modulation of endogenous noradrenaline release from adrenergic terminals in the guinea-pig colon

Journal of Autonomic Pharmacology

Volumn 17, Issue 6, 1997, Pages 365-372

  Marino, F ^a   Cosentino, M ^a   De Ponti, F ^a   Giaroni, C ^a   Somaini, L ^a   Bombelli, R ^a   Ferrari, M ^a   Aasen, A J ^b   Lecchini, S ^a   Frigo, G ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

4 DIPHENYLACETOXY 1 METHYLPIPERIDINE; ACETYLCHOLINE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR ANTAGONIST; MUSCARINIC M2 RECEPTOR ANTAGONIST; MUSCARINIC M3 RECEPTOR ANTAGONIST; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; NORADRENALIN; OTENZEPAD; OXOTREMORINE; SCOPOLAMINE; TELENZEPINE; TETRODOTOXIN; TRIHEXYPHENIDYL;

ADRENERGIC NERVE; ADRENERGIC SYSTEM; ANIMAL TISSUE; ARTICLE; COLON; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTERNEURON; INTESTINE INNERVATION; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC NERVE;

EID: 7144253782     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2680.1997.00057.x     Document Type: Article

References (45)

1. 3H-NA from guinea-pig ileum myenteric nerve terminals. Acta Physiol. Scand., 116, 83-92.
2. ANTON, A.H. & SAYRE, D.F. (1962). A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J. Pharmacol. Exp. Ther., 138, 360-375.
3. BARLOW, R.B. (1995). Use of an antagonist for estimating the degree of agonist stimulation during physiological release. Trends Pharmacol, Sci., 16, 262-264.
4. 3H]-NA release on rabbit iris in vitro: effects of stimulation conditions on intrinsic activity of methacholine and pilocarpine. Br. J. Pharmacol., 94, 890-900.
5. 1 muscarinic cholinoceptors mediating facilitation of noradrenaline release in guinea-pig carotid arteries. Naunyn-Schmiedeberg's Arch. Pharmacol., 346, 391-394.
6. CASADO, M.A., SEVILLA, M.A., ALONSO, M.J., MARIN, J. & SALAICES, M. (1994). Muscarinic receptors involved in modulation of norepinephrine release and vasodilatation in guinea pig carotid arteries. J. Pharmacol. Exp. Ther., 271, 1638-1646.
7. COSENTINO, M., MARINO, F., DE PONTI, F., GIARONI, C., SOMAINI, L, LEONI, O., LECCHINI, S. & FRIGO, G.M. (1995a). Tonic modulation of neurotransmitter release in the guinea-pig myenteric plexus: effect of μ. and κ opioid receptor blockade and of chronic sympathetic denervation. Neuroscience Letters, 194, 185-188.
8. COSENTINO, M., DE PONTI, F., MARINO, F., GIARONI, C., LEONI, O., LECCHINI, S. & FRIGO, G.M. (1995b). N-methyl-D-aspartate receptors modulate neurotransmitter release and peristalsis in the guinea-pig isolated colon. Neuroscience Letters, 183, 139-142.
9. COSTA, M. & MAJEWSKI, H. (1991). Evidence for facilitatory and inhibitory muscarinic receptors on postganglionic sympathetic nerves in mouse isolated atria. Br. J. Pharmacol., 102, 855-860.
10. 1 muscarinic receptors enhance noradrenaline release in mouse atria by activating protein kinase C. Br. J. Pharmacol., 110, 910-916.
11. DE PONTI, F., GIARONI, C., COSENTINO, M., LECCHINI, S. & FRIGO, G.M (1996). Adrenergic mechanisms in the control of gastrointestinal motility: from basic science to clinical applications. Pharmacol. Ther.,69, 59-78.
12. 3 muscarinic receptors in the circular muscle of the guinea-pig ileum. Naunyn-Schmiedeberg's Arch. Pharmacol., 351, 237-243.
13. DOODS, H.N., DAVIDESKO, D., DE JONGE, A. & VAN ZWIETEN, P.A. (1987). The selectivity of muscarinic antagonists as assessed in radioligand binding and in vivo experiments. In: Cellular and Molecular Basis of Cholinergic Function, pp. 78-85. Eds M.J. Dowdall & J.N. Hawthorne. Ellis Horwood:Chichester.
14. DÖRJE, F., WESS, J., LAMBRECHT, G., TACKE, R., MUTSCHLER, E. & BRANN, M.R. (1991). Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol. Exp. Ther., 256, 727-733.
15. 2 receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens. Eur. J. Pharmacol., 151, 205-221.
16. GALVAN, M., BOER, R. & SCHUDT, C. (1989). Interaction of telenzepine with muscarinic receptors in mammalian sympathetic ganglia. Eur. J. Pharmacol., 167, 1-10.
17. GRIMM, U., FUDER, H., MOSER, U., BÄUMERT, H.G., MUTSCHLER, E. & LAMBRECHT, G. (1994). Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol., 349, 1-10.
18. 1 muscarine receptor at postganglionic cardiac noradrenergic nerve fibres that is activated by endogenous acetylcholine. Naunyn-Schmiedeberg's Arch. Pharmacol., 342, 483-489.
19. HURST, S. & COLLINS, S.M. (1993). Interleukin-1 beta modulation of norepinephrine release from myenteric neurons. Am. J. Physiol., 264, G30-G35.
20. 1 muscarinic receptors modulating acetylcholine release from postsynaptic muscarinic receptors in the guinea-pig ileum. Gen. Pharmacol., 21, 17-21.
21. 1 muscarine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 343, 7-13.
22. MANABE, N., FOLDES, F.F., TÖRÖCSIK, A., NAGASHIMA, H., GOLDINER, P.L. & VIZI, E.S. (1991). Presynaptic interaction between vagal and sympathetic innervation in the heart: modulation of acetycholine and noradrenaline release. J. Auton. Nerv. Syst., 32, 233-242.
23. MANBER, L. & GERSHON, M.D (1979). A reciprocal adrenergic-cholinergic axoaxonic synapse in the mammalian gut. Am. J. Physiol., 236, E738-E745.
24. 2-adrenoceptor agonists after chronic sympathetic denervation. Naunyn-Schmiedeberg's Arch. Pharmacol., 329, 271-277.
25. MARINO, F., CRETA, F., DE PONTI, F., GIARONI, C., LECCHINI, S. & FRIGO, G.M. (1993). Opioid pathways exert a tonic restraint in the guinea-pig isolated colon: changes after chronic sympathetic denervation. J. Pharm. Pharmacol., 45, 668-670.
26. MARINO, F., MARCOLI, M., DE PONTI, F., COSENTINO, M., LECCHINI, s. & FRIGO, G.M. (1994). Effect of desipramine-induced blockade of neural uptake mechanisms on adrenoceptor-mediated responses in the guinea-pig colon. Naunyn-Schmiedeberg's Arch. Pharmacol., 350, 499-506.
27. MICHEL, A.D. & WHITING, R.L. (1987). Direct binding studies on ileal and Cardiac muscarinic receptors. Br. J. Pharmacol., 92, 755-767.
28. 3H]4DAMP. Eur. J. Pharmacol., 166, 459-466.
29. MUSCHOLL, E. (1980). Peripheral muscarinic control of noradrenaline release in the cardiovascular system. Am. J. Physiol., 239, H713-H720.
30. NAKAYAMA, S., TANIYAMA, K., MATSUYAMA, S., OHGUSHI, N., TSUNEKAWA, K. & TANAKA, C. (1990). Regulatory role of enteric mu and kappa opioid receptors in the release of acetylcholine and norepinephrine from guinea-pig ileum. J. Pharmacol. Exp. Ther., 254, 792-798.
31. 2 receptors mediated depolarization and presynaptic inhibition in guinea-pig enteric nervous system. J. Physiol., 368, 435-452.
32. ONALI, P., AASEN, A.J. & OLIANAS, M.C. (1994). Antagonism by (R)- and (S)-trihexyphenidyl of muscarinic stimulation of adenylyl cyclase in rat olfactory bulb and inhibition in striatum and heart. Br. J. Pharmacol., 113, 775-780.
33. PATON, W.D.M. & VIZI, E.S. (1969). The inhibitory action of noradrenaline and adrenaline on acetylcholine output by guinea-pig ileum longitudinal muscle strip. Br, J. Pharmacol, 35, 10-28.
34. RACKé, K., BäHRING, A., BRUNN, G., ELSNER, M. & WESSLER, I. (1991). Characterization of endogenous noradrenaline release from intact and epithelium-denuded rat isolated trachea. Br. J. Pharmacol., 103, 1213-1217.
35. RACKE, K., BFRRINO, L., MÖHLlG, A., JÄGER, R., GRIEPENKERL, I., BRÄUTIGAM, M. & REIMANN, A. (1995). Modulation of noradrenaline release in rat isolated stomach by prostanoids, but not by histaminergic mechanisms. Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 631-639.
36. SCHUDT, C., BOER, R., ELTZE, M., RIEDEL, R., GRUNDLER, G. & BIRDSALL, N.J.M. (1989). The affinity, selectivity and biological activity of telenzepine enantiomers. Ear. J. Pharmacol., 165, 87-96.
37. 2 receptor stimulation on transmitter release. J. Neurochem., 56, 1466-1470.
38. STARKE, K. (1977). Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol., 77, 1-124.
39. TALLARIDA, R.J. & MURRAY, R.B. (1987). Manual of Pharmacologic Calculations with Computer Programs. Springer:New York, Berlin, Heidelberg.
40. THATlKUNTA, P., CHAKDER, S & RATTAN, S. (1993). Nitric Oxide synthase inhibitor inhibits catecholamines release caused by hypogastric sympathetic nerve stimulation. J. Pharmacol. Exp. Ther., 267, 1363-1368.
41. VANHOUTTE, P.M. & LEVY, M.N. (1980). Prejunctional cholinergic modulation of adrenergic neurotransmission in cardiovascular system. Am. J. Physiol., 238, H275-H281.
42. WAELBROECK, M., CAMUS, J., TASTENOY, M., MUTSCHLER, E., STROHMANN, C., TACKE, R., SCHJELDERUP, L., AASEN, A., LAMBRECHT, G. & CHRISTOPHE, J. (1992). Stereoselective interaction of procyclidine, hexahydrodifenidol, hexbutinol and oxyphencyclinine, and of related antagonists, with four muscarinic receptors. Eur. J. Pharmacol. (Mol Pharmacol. Sect.), 227, 33-42.
43. WESTFALL, T.C. (1977). Local regulation of adrenergic neurotransmission. Physiol. Rev., 57, 659-728.
44. WIKBERG, J.E.S. & LEFKOWITZ, R.J. (1982). Alpha2 adrenergic receptors are located prejunctionally in the Auerbach's plexus of the guinea-pig small intestine: direct demonstration by radioligand binding. Life Sci., 31, 2899-2905.
45. 2 muscarinic receptor-mediated inhibition of endogenous noradrenaline release from the isolated vascularly perfused rat stomach. J. Pharmacol. Exp. Ther., 264, 54-60.